2 completed, 2 terminated. 2 Phase 3, 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Terminated 2 |
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow aclerastide: new trials by email Literature Review of aclerastide trials Research Report on aclerastide
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of the Safety of USB005 in Healthy Volunteers USB005 (aclerastide) Ophthalmic Solution, USB005 Ophthalmic Solution Placebo - Healthy Volunteers | Phase 1 | Completed | US Biotest, Inc. | 32 | 2018-07-25 | 2019-04-04 |
| Phase 3 Study Evaluating Efficacy and Safety of DSC127 Compared With Vehicle and With Standard-of-care in Diabetic Foot Ulcers DSC127, placebo vehicle gel, Standard of Care gel, Aquasite - Diabetic Foot Ulcers | Phase 3 | Terminated | Integra LifeSciences Corporation | 396 | 2013-04-01 | 2017-12-12 |
| Phase III Study to Evaluate Efficacy and Safety of DSC127 in Diabetic Foot Ulcers DSC127, placebo vehicle gel - Diabetic Foot Ulcers | Phase 3 | Terminated | Integra LifeSciences Corporation | 266 | 2013-02-01 | 2017-12-12 |
| Safety and Efficacy Study of DSC127 in Treating Subjects With Diabetic Ulcers NorLeu3-A(1-7) in a gel formulation - Foot Ulcer, Diabetic, Diabetic Foot | Phase 2 | Completed | US Biotest, Inc. | 78 | 2008-10-01 | 2012-09-27 |
Diabetic Foot (3) · Corneal Injuries (1) · Diabetes Mellitus (1) · Diabetic Neuropathies (1) · Infections (1) · Peripheral Vascular Diseases (1)
Integra LifeSciences Corporation (2) · US Biotest, Inc. (2)
United States (4) · Canada (1) · Puerto Rico (1) · South Africa (1)
Alan Dunton, MD (1) · Michael Sheety, MD (1)